Genomics of Drug Sensitivity in Cancer |
Bryostatin 1
|
Synonyms |
Bryostatin
|
Targets |
PKC
|
Target pathway |
Other, kinases
|
PubCHEM ID |
5280757
|
Jsmol |
|
Download molecule |
5280757
|
PUBCHEM IUPAC INCHI |
InChI=1S/C47H68O17/c1-10-11-12-13-14-15-39(51)62-43-31(22-41(53)58-9)21-34-25-37(28(2)48)61-42(54)24-32(50)23-35-26-38(59-29(3)49)45(6,7)46(55,63-35)27-36-19-30(20-40(52)57-8)18-33(60-36)16-17-44(4,5)47(43,56)64-34/h12-17,20,22,28,32-38,43,48,50,55-56H,10
|
Smiles |
O=C1(OC(C(O)C)CC4(OC(O)(C(C=CC3(CC(CC(CC2(OC(CC(C1)O)CC(OC(=O)C)C2(C)C)(O))O3)=CC(=O)OC))(C)C)C(OC(=O)C=CC=CCCC)C(C4)=CC(=O)OC))
|
Cluster number |
103
|
calculated LogS |
-6,078
|
Molecular weight |
905,04
|
calculated LogP |
5,0065
|
H-Acceptors |
17
|
H-Donors |
4
|
Ro5 violations |
3
|
Druglikeness |
-8,6194
|
DrugScore |
7,10090243058381E-02
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
high
|
Fish Toxicity |
High FHMT
|
Fish Toxicity2 |
1,0195
|
Rat Acute Toxicity |
3,0483
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2-
|
Caco-2 Permeability2 |
0,6857
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor2 |
Inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
1,1159
|
AMES Toxicity |
Non AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB-
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
High HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Mitochondria
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-3,9638
|